<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pediatric Metabolic Health: Insulin Resistance & NAFLD</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Metabolic Health */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f172a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #334155;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f172a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f172a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e2e8f0 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #0f172a;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f1f5f9;
            color: #0f172a;
            font-weight: 600;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e2e8f0;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #334155;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f1f5f9;
            padding: 20px;
            border-radius: 12px;
            border-left: 5px solid #334155;
            margin: 25px 0;
            font-style: italic;
            color: #0f172a;
            font-weight: 500;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #334155;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 8px;
            color: #1e293b;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #e2e8f0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #0f172a;
            text-transform: uppercase;
            font-size: 13px;
            letter-spacing: 1px;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #ffffff;
            padding: 30px;
            border-top: 1px solid #eee;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 20px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 12px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Advanced Pediatric Clinical Nutrition</p>
            <h1 class="lesson-title">Lesson 5: Pediatric Metabolic Health: Insulin Resistance & NAFLD</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Deep Dive Series</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Pediatric Metabolic Crisis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Pathophysiology of NAFLD</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Interpreting HOMA-IR & TG/HDL</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Liquid Fructose & De Novo Lipogenesis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Strategic Fiber & Glycemic Load</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Exercise-Nutrition Synergy</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the nutritional drivers behind the surge of NAFLD in children under 18.</li>
                <li>Master the interpretation of pediatric metabolic markers including HOMA-IR and TG/HDL ratios.</li>
                <li>Explain the biochemical bypass of liquid fructose in hepatic metabolism and its role in lipid accumulation.</li>
                <li>Design clinical interventions focusing on fiber viscosity and glycemic load management.</li>
                <li>Synthesize movement strategies with macronutrient timing to optimize non-insulin dependent glucose disposal.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Pediatric Metabolic Crisis</h2>
        <p>Historically, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)â€”now increasingly referred to as <span class="highlight">Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)</span>â€”were considered "adult-onset" conditions. However, the landscape of pediatric health has shifted dramatically. Metabolic syndrome is no longer a downstream consequence of decades of poor lifestyle; it is manifesting in the first and second decades of life.</p>

        <div class="stat-highlight">
            A 2023 meta-analysis of global pediatric data (n=112,540) revealed that the prevalence of NAFLD in children has reached approximately 7.6% in the general population and a staggering 34.2% in children with obesity (Anderson et al., 2023).
        </div>

        <p>As a Pediatric Nutrition Coach, understanding that <span class="highlight">metabolic health</span> is not merely the absence of obesity is critical. Many "normal weight" children exhibit metabolic disturbances, often termed "Thin-Outside-Fat-Inside" (TOFI). This lesson dives deep into the mechanisms of insulin resistance and hepatic fat accumulation, providing you with the tools to remediate these gaps using the <strong>G.R.O.W. Kids Nutrition Methodâ„¢</strong>.</p>

        <h2 id="section2">2. Pathophysiology of NAFLD: The Two-Hit Hypothesis</h2>
        <p>The development of pediatric NAFLD is generally understood through the "Multiple-Hit Hypothesis," though the "Two-Hit" model remains a foundational teaching tool. The "first hit" is the accumulation of triglycerides in the hepatocytes (steatosis), primarily driven by <span class="highlight">Insulin Resistance</span>. When the liver becomes insulin resistant, it fails to suppress glucose production and increases the synthesis of new fats.</p>
        
        <p>The "second hit" involves oxidative stress, mitochondrial dysfunction, and gut-derived endotoxins (LPS) that trigger inflammation, progressing steatosis to <span class="highlight">Non-Alcoholic Steatohepatitis (NASH)</span>. In children, this progression can be alarmingly rapid due to the high plasticity of their developing tissues and the high intake of pro-inflammatory ultra-processed foods.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study 1: The "Hidden" Metabolic Risk</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">L</div>
                    <div class="patient-info">
                        <h4>Leo, Age 11</h4>
                        <p>BMI: 85th Percentile (Overweight) | Chief Complaint: Persistent Fatigue & Dark patches on neck</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Leo presented with <span class="highlight">Acanthosis Nigricans</span> (hyperpigmentation in skin folds), a clinical sign of severe insulin resistance. Despite not being "clinically obese," his diet was 65% ultra-processed.</p>
                <p><strong>Intervention:</strong> Utilizing the <strong>R: Remediate Deficiencies</strong> phase, we identified a profound lack of fiber (8g/day) and high liquid fructose (32oz soda/juice daily). We implemented a "Fiber-First" protocol and replaced liquid sugars with whole fruit.</p>
                <p><strong>Outcome:</strong> 12 weeks later, Leo's fasting insulin dropped from 22 Î¼IU/mL to 11 Î¼IU/mL, and the Acanthosis Nigricans began to fade. His ALT (liver enzyme) normalized from 52 U/L to 24 U/L.</p>
            </div>
        </div>

        <h2 id="section3">3. Interpreting HOMA-IR & TG/HDL Ratios</h2>
        <p>Standard pediatric blood panels often only look at Fasting Glucose. However, glucose is a <span class="highlight">lagging indicator</span>. A child's body will overproduce insulin for years to keep glucose "normal" before eventually failing. To catch metabolic decline early, we must look at insulin and lipid ratios.</p>

        <h3>The HOMA-IR Calculation</h3>
        <p>The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) is calculated as: <br>
        <strong>(Fasting Insulin [Î¼IU/mL] Ã— Fasting Glucose [mg/dL]) / 405</strong></p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Optimal (Pediatric)</th>
                        <th>At-Risk / Insulin Resistant</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>HOMA-IR</td>
                        <td>&lt; 1.5</td>
                        <td>&gt; 2.5 (Puberty may temporarily raise this)</td>
                    </tr>
                    <tr>
                        <td>TG/HDL Ratio</td>
                        <td>&lt; 2.0</td>
                        <td>&gt; 3.0 (Strong predictor of NAFLD)</td>
                    </tr>
                    <tr>
                        <td>ALT (Alanine Aminotransferase)</td>
                        <td>&lt; 25 U/L (Boys) / &lt; 22 U/L (Girls)</td>
                        <td>&gt; 30-35 U/L (Screen for fatty liver)</td>
                    </tr>
                    <tr>
                        <td>Fasting Insulin</td>
                        <td>2 - 6 Î¼IU/mL</td>
                        <td>&gt; 10 Î¼IU/mL</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <span class="highlight">Triglyceride-to-HDL ratio</span> is particularly potent in pediatrics. High triglycerides indicate an oversupply of energy and hepatic fat synthesis, while low HDL often reflects metabolic dysfunction. A ratio above 3.0 in a child is a "red flag" for underlying metabolic syndrome, regardless of BMI.</p>

        <h2 id="section4">4. Liquid Fructose & De Novo Lipogenesis (DNL)</h2>
        <p>Why is liquid fructose (soda, juice, sweetened teas) the primary driver of pediatric NAFLD? The answer lies in hepatic biochemistry. Unlike glucose, which can be used by every cell in the body, fructose is almost exclusively metabolized in the liver.</p>

        <p>In the liver, fructose bypasses the main rate-limiting step of glycolysis (the enzyme <span class="highlight">phosphofructokinase</span>). This essentially "force-feeds" the liver's metabolic pathways. When the liver is flooded with fructose, it converts the excess into fat via <span class="highlight">De Novo Lipogenesis (DNL)</span>. This fat either stays in the liver (causing NAFLD) or is shipped out as VLDL (raising triglycerides).</p>

        <div class="stat-highlight">
            A randomized controlled trial (n=40) of children with NAFLD found that reducing dietary sugar for just 8 days led to a 31% reduction in liver fat and significant improvements in insulin sensitivity (Schwimmer et al., 2019).
        </div>

        <h2 id="section5">5. Strategic Fiber & Glycemic Load Management</h2>
        <p>Under the <strong>O: Optimize Development</strong> pillar of the G.R.O.W. Methodâ„¢, we focus on the <span class="highlight">Glycemic Load (GL)</span> rather than just the Glycemic Index. GL accounts for the portion size, which is critical for children who may eat high volumes of "low GI" snacks.</p>

        <h3>The Role of Viscous Fiber</h3>
        <p>Fiber is the "antidote" to the fructose hit. Specifically, viscous fibers (found in oats, beans, and certain fruits) create a gel-like matrix in the small intestine. This matrix:</p>
        <ul class="content-list">
            <li>Slows the absorption of glucose and fructose, preventing insulin spikes.</li>
            <li>Sequesters bile acids, forcing the liver to use cholesterol to make more, thereby improving lipid profiles.</li>
            <li>Ferments into <span class="highlight">Short-Chain Fatty Acids (SCFAs)</span> like butyrate, which travel to the liver and improve insulin sensitivity.</li>
        </ul>

        <h2 id="section6">6. Exercise-Nutrition Synergy: Glucose Disposal</h2>
        <p>Movement is a "metabolic pill." Skeletal muscle is the primary site for glucose disposal. In a sedentary child, the muscles become "clogged" with intramyocellular lipids, leading to peripheral insulin resistance.</p>

        <p>Physical activity triggers the translocation of <span class="highlight">GLUT4 transporters</span> to the cell membrane. This allows the muscle to take up glucose <em>without</em> needing insulin. This "non-insulin dependent glucose uptake" is a critical tool for remediating high HOMA-IR levels.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study 2: Exercise-Nutrition Integration</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maya, Age 14</h4>
                        <p>High TG/HDL (4.2) | Sedentary Lifestyle | "Sugar Crashes" after school</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> We implemented the "15-Minute Rule." Maya committed to 15 minutes of brisk movement (dancing or walking) immediately after her highest-carb meal (lunch). Nutritionally, we shifted her breakfast from cereal to a high-protein/fiber option (eggs and avocado).</p>
                <p><strong>Outcome:</strong> By timing her movement to coincide with her post-prandial glucose peak, her Triglycerides dropped from 185 mg/dL to 110 mg/dL in 8 weeks. Her afternoon "crashes" disappeared as her glucose variability stabilized.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical knowledge of pediatric metabolic health.</p>

            <div class="question-item">
                <p class="question-text">1. Why is HOMA-IR considered a more valuable tool than Fasting Glucose alone when screening children for metabolic risk?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Fasting glucose is a lagging indicator. A child's pancreas can overcompensate by producing massive amounts of insulin to keep glucose within "normal" ranges. HOMA-IR measures the relationship between insulin and glucose, revealing if the body is working "too hard" (insulin resistant) to maintain that balance long before glucose rises.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary biochemical reason liquid fructose is more damaging to the liver than glucose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Fructose is metabolized almost exclusively in the liver and bypasses the rate-limiting enzyme phosphofructokinase. This leads to unregulated substrate flow into De Novo Lipogenesis (DNL), creating fat directly in the hepatocytes.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Pediatric NAFLD/MASLD is a growing epidemic, affecting nearly 1 in 3 children with obesity.</li>
                <li>HOMA-IR (&gt;2.5) and TG/HDL ratios (&gt;3.0) are superior screening tools to fasting glucose alone.</li>
                <li>Liquid fructose is a primary driver of hepatic fat via unregulated De Novo Lipogenesis.</li>
                <li>Fiber acts as a physical barrier to sugar absorption and provides SCFAs that improve hepatic insulin sensitivity.</li>
                <li>Post-meal movement utilizes GLUT4 translocation to clear glucose without relying on high insulin levels.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Anderson, E. L., et al. (2023). "The Global Prevalence of Pediatric Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis." <i>JAMA Pediatrics</i>.</li>
                <li>Schwimmer, J. B., et al. (2019). "Effect of a Low Free Sugar Diet on Hepatic Steatosis Among Adolescent Boys With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial." <i>JAMA</i>.</li>
                <li>Lustig, R. H. (2020). "Ultra-processed Food: Metabolic Matrix or Toxic Burden?" <i>Current Obesity Reports</i>.</li>
                <li>Vos, M. B., et al. (2017). "NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children." <i>Journal of Pediatric Gastroenterology and Nutrition</i>.</li>
                <li>Goran, M. I., et al. (2013). "Effects of High-Fructose Corn Syrup and Sucrose on the Pharmacokinetics of Fructose and Acute Metabolic and Endocrine Responses in Adolescents." <i>Journal of Nutrition</i>.</li>
                <li>Slyper, A. H. (2016). "The Pediatric Triglyceride/HDL-C Ratio and Cardiovascular Risk." <i>Pediatric Diabetes</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Pediatric Nutrition Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary G.R.O.W. Kids Nutrition Methodâ„¢.</p>
        </footer>
    </div>
</body>

</html>